ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.55
1.45%
US Tech 100
20,158.00
0.16%
S&P 500
5,948.71
0.53%
US Dollar vs CAD
1.39735
-0.05%
Bitcoin
98,142.74
-0.38%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ARS Pharmaceuticals Inc (SPRY)

  7. ARS Pharmaceuticals Inc (SPRY) News

ARS Pharmaceuticals Inc

ARS Pharmaceuticals Inc (SPRY)

NASDAQ
13.38
-0.17
(-1.25%)
At close: November 21 3:00PM
Delayed by 15 minutes
13.35
-0.03
( -0.22% )
After Hours: 6:26PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

SPRY News

Official News Only

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
3 hours ago
SPRY (-1.25%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
November 15 2024
SPRY (-1.25%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
November 14 2024
SPRY (-1.25%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
November 13 2024
SPRY (-1.25%)

Form 8-K - Current report
Edgar (US Regulatory)
November 13 2024
SPRY (-1.25%)

Form 8-K - Current report
Edgar (US Regulatory)
November 12 2024
SPRY (-1.25%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
October 17 2024
SPRY (-1.25%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
October 17 2024
SPRY (-1.25%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
October 16 2024
SPRY (-1.25%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
October 15 2024
SPRY (-1.25%)

Form 8-K - Current report
Edgar (US Regulatory)
October 15 2024
SPRY (-1.25%)

SPRY Discussion

View Posts
JJPK JJPK 2 months ago
Trading like news is eminent
👍️0
stocksrising stocksrising 3 months ago
I’m In!! Going long, and selling naked Nov 12.5 puts ( almost $2 per put) GLTA
👍️0
EnchantedTitan62 EnchantedTitan62 3 months ago
Good call on the inhalent, last week FDA approved. Moving up again today. 👍
👍️ 1
JJPK JJPK 5 months ago
Close to 3mil shares traded in the last minute of trading.
Whats Up.??
👍️0
Monksdream Monksdream 7 months ago
SPRY under $10

👍️0
erik007tc erik007tc 7 months ago
I believe the fda review/approval will be within 6 months.
👍️ 1
Monksdream Monksdream 8 months ago
SPRY over $10
Next day settlement begins 5/28 per SEC mandate
👍️0
dodgerdog dodgerdog 8 months ago
Good News around the corner? 🙂
👍️ 1 🤑 1
gail gail 1 year ago
ah, should have held, lol
👍️0
gail gail 1 year ago
not in as i hopped in something else, but watching now.
👍️0
Pt3 Pt3 1 year ago
It not going up anytime soon but down Fda denied news
👍️0
gail gail 1 year ago
why not?
👍️0
Pt3 Pt3 1 year ago
Why buy
👍️0
gail gail 1 year ago
i grabbed some today too.
👍️0
makinezmoney makinezmoney 1 year ago
$SPRY:: Fabulous dump down to $2.60 here...............................


OKkkkkkkkkkkkkkkkkkkk.......... lets gooooooooooooooo


GO $SPRY
👍️0
MiamiGent MiamiGent 2 years ago
SPRY Also in ...
ARS PHARMACEUTICALS INC
Pre-market the price per share is $7.85 +$0.10 (1.29%)

https://stockcharts.com/h-sc/ui?s=SPRY

Wedbush Reiterates Outperform on ARS Pharmaceuticals, Maintains $17 Price Target
BENZINGA
8:34 AM ET May-18-2023
Wedbush analyst Andreas Argyrides reiterates ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform and maintains $17 price target.
👍️0
MiamiGent MiamiGent 2 years ago
SPRY This is spraying profits all over my screen this morning! I have a very green screen! What's going on, I'm trying to glean.

https://stockcharts.com/h-sc/ui?s=SPRY
👍️0
MiamiGent MiamiGent 2 years ago
SPRY $8.32 +$0.28 (+3.483%)
Moving up after waffling this morning
Volume
2,403,836
90 Day Avg. Vol.
927,230

https://stockcharts.com/h-sc/ui?s=SPRY
👍️0

Your Recent History

NASDAQ
SPRY
ARS Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved